These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 20167655)

  • 1. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
    Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
    Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization.
    Hasselberg A; Ekman L; Yrlid LF; Schön K; Lycke NY
    J Immunol; 2010 Mar; 184(6):2776-84. PubMed ID: 20142362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
    Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions.
    Takeda M; Yamashita T; Sasaki N; Nakajima K; Kita T; Shinohara M; Ishida T; Hirata K
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2495-503. PubMed ID: 20930170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
    Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
    Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory CD4
    Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
    Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.
    Deshpande V; Krishnan R; Philip S; Faludi I; Ponnusamy T; Thota LN; Endresz V; Lu X; Kakkar VV; Mundkur LA
    Cardiovasc Ther; 2016 Oct; 34(5):314-24. PubMed ID: 27241889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
    Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
    Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
    Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.